• Home
  • NEW DAY MEDICINE
  • 12 (86) 2025
  • 125 -12 (86) 2025 - Tashmukhammadova S.Z., Radjabov O.A. - COMPREHENSIVE TREATMENT OF ORAL MUCOSAL DISEASES IN PATIENTS WITH EPILEPSY TAKING INTO ACCOUNT MEDICAMENTOUS AND NEUROIMMUNE FACTORS

125 -12 (86) 2025 - Tashmukhammadova S.Z., Radjabov O.A. - COMPREHENSIVE TREATMENT OF ORAL MUCOSAL DISEASES IN PATIENTS WITH EPILEPSY TAKING INTO ACCOUNT MEDICAMENTOUS AND NEUROIMMUNE FACTORS

COMPREHENSIVE TREATMENT OF ORAL MUCOSAL DISEASES IN PATIENTS WITH EPILEPSY TAKING INTO ACCOUNT MEDICAMENTOUS AND NEUROIMMUNE FACTORS

Tashmukhammadova S.Z. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Radjabov O.A. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Oral mucosal diseases in patients with epilepsy are characterized by high prevalence, a chronic course, and pronounced resistance to standard dental treatment methods. Long-term antiepileptic therapy, neuroimmune disorders, and alterations in local oral homeostasis play a significant role in the development of these lesions. Ignoring these factors leads to frequent relapses and reduced treatment effectiveness. The aim of this study is to evaluate the effectiveness of comprehensive treatment of oral mucosal diseases in patients with epilepsy, taking into account medicamentous and neuroimmune factors. The article presents clinical and laboratory data, an analysis of the effects of antiepileptic drugs, and a rationale for differentiated therapeutic approaches.

Keywords: epilepsy, oral mucosa, antiepileptic drugs, neuroimmune disorders, comprehensive treatment.

First page

694

Last page

698

For citation:Tashmukhammadova S.Z., Radjabov O.A. - COMPREHENSIVE TREATMENT OF ORAL MUCOSAL DISEASES IN PATIENTS WITH EPILEPSY TAKING INTO ACCOUNT MEDICAMENTOUS AND NEUROIMMUNE FACTORS//New Day in Medicine 12(86)2025 694-698 https://newdayworldmedicine.com/en/new_day_medicine/12-86-2025

List of References

  1. Авакян Г. Н., Белоусова Е. Д. Эпилепсия: клиника, диагностика и лечение. — М.: ГЭОТАР-Медиа, 2018. — 368 с.
  2. Карлов В. А. Эпилепсия у взрослых и детей. — М.: Медицина, 2017. — 432 с.
  3. Шмаков А. Н., Кулаков А. А. Заболевания слизистой оболочки полости рта: клинико-патогенетические аспекты. — М.: Практическая медицина, 2019. — 256 с.
  4. Григорьян А. С., Рабинович О. Ф. Заболевания слизистой оболочки полости рта. — М.: ГЭОТАР-Медиа, 2016. — 304 с.
  5. Данилов А. Б., Шихкеримов Р. К. Побочные эффекты противоэпилептической терапии // Неврологический журнал. — 2018;3:25–31.
  6. Пономарёв А. В., Юмашев А. В. Гиперплазия дёсен, индуцированная приёмом лекарственных средств // Стоматология. — 2017;5:48–53.
  7. Ронь Г. И., Гажва С. И. Иммунологические аспекты заболеваний слизистой оболочки полости рта // Клиническая стоматология. — 2019;1:14–19.
  8. Петрушин В. В., Нурмухамедов Х. А. Состояние полости рта у пациентов с хроническими неврологическими заболеваниями // Вестник стоматологии. — 2020;2:37–42.
  9. Scannapieco F. A., Bush R. B., Paju S. Associations between periodontal disease and systemic conditions // Annals of Periodontology. — 2003;8(1):54–69.
  10. Munro C. L., Grap M. J. Oral health and care in neurologically compromised patients // American Journal of Critical Care. — 2004;13(1):25–33.

    file

    download